Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

There is some evidence that statins may have a protective and symptomatic benefit in Alzheimer disease (AD). The LEADe study is a randomized controlled trial (RCT) evaluating the efficacy and safety of atorvastatin in patients with mild to moderate AD. This was an international, multicenter, double-...

Full description

Saved in:

Bibliographic Details
Published in:	Neurology Vol. 74; no. 12; p. 956
Main Authors:	Feldman, H H, Doody, R S, Kivipelto, M, Sparks, D L, Waters, D D, Jones, R W, Schwam, E, Schindler, R, Hey-Hadavi, J, DeMicco, D A, Breazna, A
Format:	Journal Article
Language:	English
Published:	United States 23.03.2010
Subjects:	Aged Aged, 80 and over Alzheimer Disease - drug therapy Alzheimer Disease - metabolism Atorvastatin Calcium Cholesterol, LDL - metabolism Cholinergic Antagonists - therapeutic use Double-Blind Method Female Heptanoic Acids - therapeutic use Hippocampus - pathology Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Magnetic Resonance Imaging Male Middle Aged Organ Size - drug effects Pyrroles - therapeutic use
ISSN:	1526-632X, 1526-632X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!